Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.
Advanced to the highest dose level in the Phase 1 dose-escalation clinical study of BDC-3042 in patients with advanced cancersPresented updated preclinical activity of BDC-4182 and key learnings...
BDC-4182 demonstrated compelling anti-tumor activity and an acceptable safety profile in preclinical studies BDC-4182 outperformed cytotoxic claudin 18.2 ADCs in syngeneic model Learnings from...
REDWOOD CITY, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of...
REDWOOD CITY, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of...
Advanced to Cohort 6 in the Phase 1 dose-escalation clinical study of BDC-3042 in patients with advanced cancersAbstract accepted for BDC-4182, a claudin 18.2-targeting BoltbodyTM ISAC at the...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0792 | 14.1428571429 | 0.56 | 0.65 | 0.56 | 175045 | 0.60431815 | CS |
4 | -0.0098 | -1.51001540832 | 0.649 | 0.69 | 0.54 | 119579 | 0.60028605 | CS |
12 | -0.012 | -1.84275184275 | 0.6512 | 0.718 | 0.54 | 142390 | 0.62405357 | CS |
26 | -0.1208 | -15.8947368421 | 0.76 | 0.795001 | 0.54 | 152964 | 0.68278043 | CS |
52 | -0.2708 | -29.7582417582 | 0.91 | 1.56 | 0.54 | 165930 | 0.87208288 | CS |
156 | -8.4608 | -92.9758241758 | 9.1 | 10.705 | 0.54 | 201756 | 1.92328558 | CS |
260 | -21.3508 | -97.0932241928 | 21.99 | 43.07 | 0.54 | 191801 | 6.66660024 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관